Safety, Tolerability, Pharmacokinetics, and Clinical Outcomes Following Single-Dose IA Administration of UBX0101, a Senolytic MDM2/p53 Interaction Inhibitor, in Patients with Knee OA Hsu, B., Visich, J., Genovese, M., Walter, K., An, M., Laberge, R., Dananberg, J. WILEY. 2019

View details for Web of Science ID 000507466905164